Midazolam vs Nivolumab
Midazolam vs Nivolumab: Overview
This comparison examines the pharmacological differences between Midazolam and Nivolumab.
Mechanism of Action
Midazolam: Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Midazolam — 1.5-2.5 hours; Nivolumab — 27 days.
Chemical Properties
Molecular Formula: Midazolam — C18H13ClFN3.
Molecular Weight: Midazolam — 325.7670 g/mol.
Type: Midazolam — Small molecule; Nivolumab — Antibody.